Recap: Aerie Pharmaceuticals Q4 Earnings

Aerie Pharmaceuticals AERI reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Aerie Pharmaceuticals beat estimated earnings by 262.69%, reporting an EPS of $1.09 versus an estimate of $-0.67.

Revenue was up $89.98 million from the same period last year.

Last quarter the company missed on EPS by $0.1 which was followed by a 1.92% increase in the share price the next day.

Here's a look at Aerie Pharmaceuticals's past performance:

Quarter	Q3 2021	Q2 2021	Q1 2021	Q4 2020
EPS Estimate	-0.62	-0.64	-0.68	-0.73
EPS Actual	-0.72	-0.67	-0.72	-0.79
Revenue Estimate	28.89M	26.28M	22.78M	22.36M
Revenue Actual	29.31M	27.18M	22.97M	24.68M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.